Published on March 14, 2016

India is probable to be among the top three pharmaceutical markets by incremental expansion and sixth largest market globally in size. India’s cost of production is appreciably lower than that of the US. It gives a competitive edge to India over others.

Presently India supply around 20 per cent of global generic medicines to make the country largest provider of generic medicines globally and expected to expand further in near term.

The Indian pharmaceutical market size is expected to grow to USD 100 billion by 2025, driven by increasing consumer spending, rapid urbanization, and raising healthcare insurance among others.
Market players have said that, the Government of India plans to incentivize bulk drug manufacturers, including both state-run and private companies, to encourage ‘Make in India’ programme and reduce dependence on imports of active pharmaceutical ingredients nearly 85 per cent of which come from China.

Market predictors have said that Indian Pharma companies will continue to grow both organically and inorganically through alliances and partnerships. They will continue to focus on improving operational efficiency and productivity which will reveal the effective growth path for industry in near future